ArticleScientific reports2026
Hardware-independent control for partial gravity simulation using a 2-DOF robotic device.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A variety of physiological changes in the human body have been observed to occur under the microgravity conditions of space. 3D clinostat devices capable of implementing time-averaged simulated microgravity (taSMG) have been widely used to predict these changes on Earth and to identify their underlying mechanisms. Recently, the concept of time-averaged simulated partial gravity (taSPG), which mimics the gravitational environments of the Moon (0.17 g) and Mars (0.38 g), has been proposed as an extension of taSMG, and clinostat control algorithms capable of implementing it have been developed. However, existing taSPG algorithms are dependent on specific hardware, limiting their versatility. Further, they are unable to generate taSPG levels exceeding 0.44 g. To address this limitation, we propose an improved control algorithm and validate it through both simulation and experiments. By applying an algorithm that does not depend on the characteristics of individual clinostat hardware, we confirmed the accurate implementation of taSPG up to 0.809 g. By adjusting the parameters, taSPG levels approaching 1 g can also be achieved. Notably, for taSPG in the range of 0.265 g to 0.635 g, the experimental values demonstrated refined accuracy with approximately 1% or less deviation from the simulation results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.